Understanding rs515726230: An Intergenic Genetic Variant
rs515726230 is an intergenic genetic variant that has been documented in clinical research databases as a rare marker. Current scientific literature provides limited information regarding specific phenotypic associations or clinical impacts for this variant.
What each genotype means
Typical genetic marker profile
This genotype represents the most common state for this specific location in the genome. Current research does not associate this specific configuration with any known clinical traits or health conditions.
This is the most frequently observed genotype across global populations.
Rare variant carrier
You carry one copy of the rare allele at this position. Because this variant is intergenic and lacks established clinical significance, this finding is considered a neutral genetic marker in current research.
This genotype is observed at a very low frequency in the general population.
Rare variant homozygous
You carry two copies of the rare allele at this position. As this variant is located in an intergenic region and is not linked to specific health outcomes in scientific literature, this result does not currently provide actionable clinical information.
This genotype is extremely rare and is found in a very small fraction of the global population.
Understanding the SNP and Its Location
A single nucleotide polymorphism, or SNP, is the most common type of genetic variation among people. It represents a difference in a single DNA building block, called a nucleotide. rs515726230 is an identifier used by international researchers to track this specific variation in the human genome. The intergenic classification means that this variant is located in the DNA sequence between genes, rather than within a gene that codes for a specific protein. Because it sits in these non-coding regions, it does not directly alter the structure of a protein. Instead, scientists investigate these regions to see if they might play a role in regulating how nearby genes are turned on or off. At this time, rs515726230 does not have a well-defined function attributed to it in public databases.
Research Associations and Evidence
In the world of genomics, many variants are identified during large-scale studies, but only a fraction are found to have a significant, measurable impact on human health. According to current records from clinical research catalogs, rs515726230 is classified as having moderate evidence strength. This description is often applied to variants identified in clinical contexts where researchers are exploring potential links to specific traits, but have not yet established a definitive, causal relationship. It is important to understand that an association is not the same as a cause. Even when a variant is statistically linked to a trait, it does not necessarily mean the variant causes that trait. Much of the current data for rare markers like rs515726230 is preliminary. As genomic research progresses, the significance of these markers can shift as more data becomes available from diverse populations and larger sample sizes.
What You Can and Cannot Do With This Information
If you have encountered rs515726230 in a personal genetic report, it is essential to view it in the context of the scientific community's current understanding. Because this is an intergenic variant with limited evidence regarding its impact, it is generally considered a neutral observation in most clinical contexts. You cannot use this information to diagnose a condition, predict your future health, or make medical decisions. Genetic data is complex, and many variants identified in research do not translate into clinical significance. If you have questions about this variant or any genetic marker mentioned in a report, the most reliable approach is to discuss it with a qualified healthcare provider or a genetic counselor. They can help you interpret the information based on your personal health history and the most up-to-date scientific guidance. Never make changes to medication or medical treatments based on genetic test results without consulting your clinician or pharmacist.
How common is this variant?
Because rs515726230 is a rare genetic marker, it is not frequently observed in general population studies. There is currently no widely recorded frequency data for this variant across different ancestral groups.
Frequently asked questions
What does it mean if my report says my variant is intergenic?
Intergenic means the variant is located in the space between genes. Since it is not inside a gene, it does not change the instructions for building a protein, though it may occasionally play a role in regulating how nearby genes function.
Is rs515726230 linked to a specific disease?
There is currently no established link between rs515726230 and any specific disease. It is a rare marker with limited evidence, and any mention of it in research is generally focused on scientific exploration rather than clinical diagnosis.
Why is there no frequency data for this variant?
Population frequency data comes from large-scale sequencing projects that look at thousands or millions of people. For very rare variants, it is common that not enough individuals have been tested to calculate a reliable percentage for different ancestral groups.
Should I be worried if I have this variant?
No. Most genetic variants identified in research are normal variations that do not have any impact on your health. Without clear, actionable evidence linking a variant to a health condition, it is usually considered a neutral piece of information.
Sources & further reading
Educational information only, last refreshed 10/3/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs515726230?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants
A variant in the cyclooxygenase-2 gene that may influence individual susceptibility to inflammatory conditions and dietary modulation.
This polymorphism in the arachidonate 5-lipoxygenase gene is investigated for its potential influence on cardiovascular disease risk and dietary response.
This SNP is linked to cardiovascular disease prevention strategies and personalized nutritional approaches.
A variant in the ALOX5 gene associated with potential modulation of inflammatory responses to dietary factors.
This variant in the 8q24 region is associated with increased prostate cancer risk in men of West African and Puerto Rican ancestry.
This variant is linked to clinical outcomes and drug response in heart failure patients.